Related Experiment Video
Updated: Jun 25, 2026
Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice
Published on: August 4, 2011
Delving Into Retinoblastoma Genetics: Discovery of Novel Mutations and Their Clinical Impact: Retrospective Cohort
Mohammad Faranoush1, Masood Naseripour2, Pooya Faranoush1,3
1Pediatric Growth and Development Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.
Insights
This study identified RB1 gene mutations in 33.5% of retinoblastoma (Rb) patients, discovering 13 novel mutations. Findings aid in managing Rb and genetic counseling for at-risk relatives.
Area of Science:
- Genetics
- Oncology
- Ophthalmology
Background:
- Retinoblastoma (Rb) is a rare childhood eye cancer.
- Germline mutations in the RB1 gene are found in about one-third of Rb cases.
Purpose of the Study:
- To identify RB1 gene mutations in retinoblastoma patients.
- To analyze the correlation between mutations and clinical outcomes.
Main Methods:
- Genomic DNA from 167 Rb patients was analyzed using Sanger sequencing and MLPA.
- Clinical data was extracted from medical records.
Main Results:
- RB1 mutations were found in 56 out of 167 (33.5%) patients.
- Common mutations included frameshift, nonsense, and splicing mutations.
- 13 novel mutations were identified, four linked to enucleation; overall survival was 98.2%.
Conclusions:
- This study offers a comprehensive analysis of RB1 germline mutations in Rb patients.
- Identified novel mutations provide insights for Rb management and genetic counseling.
- Findings are particularly relevant for a referral center in Iran and at-risk family members.
Background:
Retinoblastoma (Rb) is a rare intraocular malignancy that originates in the retina of children under 5 years of age. Approximately one-third of children diagnosed with retinoblastoma are associated with germline mutations in one of the RB1 alleles. In this study, we aim to identify RB1 mutations in retinoblastoma patients using Sanger sequencing in combination with multiplex ligation-dependent probe amplification (MLPA).
Method:
The genomic DNA of 167 Rb patients was isolated from peripheral blood and their clinical information was extracted from medical records. The mutations in the RB1 gene were identified through PCR sequencing. Negative results from the PCR sequencing were further analyzed using MLPA reactions.
Results:
RB1 mutations were identified in 56 of the 167 (33.5%) patients. The common mutation types were frameshift mutations (n = 19), followed by nonsense (n = 20), splicing (n = 8), missense (n = 5), and whole exon deletion (n = 2). The overall survival rate was 98.2%, with an average follow-up duration of 59 months. Moreover, germline RB1 mutation's correlation with enucleation rates is less pronounced in unilateral cases (12.1%) compared to bilateral cases (65.5%). A total of 13 novel mutations have been identified, of which four are specifically associated with enucleation.
Conclusion:
This study provides a comprehensive analysis of RB1 germline mutations in a group of cases with Rb, leading to the identification of 13 novel mutations in Rb patients at a referral center in Iran. We expect that our findings will yield valuable insights to inform the management and genetic counseling of Rb patients, as well as their relatives who are at a higher risk.
Related Concept Videos
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...